Cetera Investment Advisers
MIST icon

Cetera Investment Advisers’s Milestone Pharmaceuticals MIST Stock Holding History

Cetera Investment Advisers’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.9K Buy
16,368
+1,664
+11% +$2.66K ﹤0.01% 4846
2026
Q1 		$17.5K Sell
14,704
-6,018
-29% -$10.5K ﹤0.01% 4667
2025
Q4 		$41.9K Buy
+20,722
New +$44.6K ﹤0.01% 4525
2025
Q1 		– Sell
-24,731
Closed -$58.4K – 4034
2024
Q4 		$58.4K Buy
24,731
+60
+0.2% +$103 ﹤0.01% 3646
2024
Q3 		$37.5K Buy
24,671
+3,982
+19% +$5.79K ﹤0.01% 3618
2024
Q2 		$27.3K Buy
20,689
+3,262
+19% +$5.24K ﹤0.01% 3631
2024
Q1 		$31.2K Buy
+17,427
New +$28.3K ﹤0.01% 3609

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Cetera Investment Advisers's MIST Position: Q2 2026 in Review

Cetera Investment Advisers increased its Milestone Pharmaceuticals (MIST) stake by 11% in Q2 2026, buying an estimated $2.66K and bringing the position to 16,368 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4846.

Cetera Investment Advisers first reported a position in MIST in Q1 2024 and has held it in 7 quarters since. The position peaked at $58.4K in Q4 2024. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Cetera Investment Advisers held 16,368 shares of Milestone Pharmaceuticals worth $21.9K as of Q2 2026.
  • Cetera Investment Advisers bought 1,664 Milestone Pharmaceuticals shares in Q2 2026, an estimated $2.66K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4846 holding.
  • Cetera Investment Advisers first reported a position in Milestone Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • Cetera Investment Advisers's Milestone Pharmaceuticals position peaked at $58.4K in Q4 2024.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.